
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 2,660 | 96.6% | 0.29 | 3,254 | 97.0% |
| LAL(L) | 83 | 3.0% | -0.13 | 76 | 2.3% |
| CentralBrain-unspecified | 10 | 0.4% | 1.07 | 21 | 0.6% |
| VES(L) | 0 | 0.0% | inf | 3 | 0.1% |
| upstream partner | # | NT | conns TRN_VP3a | % In | CV |
|---|---|---|---|---|---|
| TRN_VP3a | 3 | ACh | 259 | 30.2% | 0.2 |
| l2LN22 (L) | 1 | unc | 243.7 | 28.4% | 0.0 |
| v2LN4 (R) | 3 | ACh | 137.3 | 16.0% | 0.2 |
| lLN2F_a (L) | 2 | unc | 67.7 | 7.9% | 0.3 |
| lLN2F_b (L) | 2 | GABA | 63.3 | 7.4% | 0.1 |
| lLN2T_b (L) | 2 | ACh | 31.7 | 3.7% | 0.5 |
| lLN2X05 (L) | 2 | ACh | 12 | 1.4% | 0.0 |
| lLN2X11 (L) | 2 | ACh | 8.7 | 1.0% | 0.4 |
| lLN2R_a (L) | 2 | GABA | 7.7 | 0.9% | 0.9 |
| lLN2X04 (L) | 2 | ACh | 7.3 | 0.9% | 0.1 |
| lLN1_bc (L) | 6 | ACh | 3.7 | 0.4% | 0.6 |
| lLN2X12 (L) | 4 | ACh | 2.7 | 0.3% | 0.6 |
| l2LN20 (L) | 3 | GABA | 2.3 | 0.3% | 0.4 |
| ALIN5 (R) | 1 | GABA | 1.3 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1.3 | 0.2% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 1.3 | 0.2% | 0.0 |
| VP3+_l2PN (L) | 2 | ACh | 1 | 0.1% | 0.3 |
| lLN2T_e (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| CB1048 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| lLN13 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| v2LN39a (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| l2LN21 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| v2LN49 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns TRN_VP3a | % Out | CV |
|---|---|---|---|---|---|
| VP3+_l2PN (L) | 3 | ACh | 1,161.3 | 28.6% | 0.4 |
| l2LN22 (L) | 1 | unc | 353 | 8.7% | 0.0 |
| VP3+_l2PN (R) | 2 | ACh | 309.7 | 7.6% | 0.4 |
| l2LN20 (L) | 3 | GABA | 300.3 | 7.4% | 0.2 |
| l2LN21 (L) | 1 | GABA | 300 | 7.4% | 0.0 |
| TRN_VP3a | 3 | ACh | 259 | 6.4% | 0.2 |
| VP5+VP3_l2PN (L) | 1 | ACh | 223 | 5.5% | 0.0 |
| lLN2T_b (L) | 2 | ACh | 144.3 | 3.5% | 0.6 |
| v2LN4 (L) | 3 | ACh | 133 | 3.3% | 0.1 |
| lLN2F_a (L) | 2 | unc | 99.7 | 2.5% | 0.2 |
| lLN2F_b (L) | 2 | GABA | 91.3 | 2.2% | 0.0 |
| v2LN4 (R) | 3 | ACh | 76.3 | 1.9% | 0.2 |
| DNb05 (L) | 1 | ACh | 74.3 | 1.8% | 0.0 |
| MZ_lv2PN (L) | 1 | GABA | 62 | 1.5% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 61.7 | 1.5% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 46.3 | 1.1% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 35 | 0.9% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 28.7 | 0.7% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 27 | 0.7% | 0.1 |
| lLN2X11 (L) | 2 | ACh | 23.7 | 0.6% | 0.0 |
| v2LN49 (L) | 2 | Glu | 23.3 | 0.6% | 0.1 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 21 | 0.5% | 0.0 |
| CB1048 (L) | 4 | Glu | 20.7 | 0.5% | 0.5 |
| M_l2PN10t19 (R) | 1 | ACh | 17 | 0.4% | 0.0 |
| M_l2PN10t19 (L) | 2 | ACh | 16 | 0.4% | 0.9 |
| lLN2X12 (L) | 4 | ACh | 16 | 0.4% | 0.6 |
| VP5+Z_adPN (L) | 1 | ACh | 15.3 | 0.4% | 0.0 |
| lLN1_bc (L) | 11 | ACh | 14 | 0.3% | 0.5 |
| lLN2X05 (L) | 2 | ACh | 10.7 | 0.3% | 0.4 |
| v2LN33 (L) | 2 | ACh | 9 | 0.2% | 0.5 |
| lLN2R_a (L) | 3 | GABA | 7.3 | 0.2% | 0.9 |
| M_l2PNm16 (L) | 2 | ACh | 7 | 0.2% | 0.0 |
| v2LN38 (R) | 2 | ACh | 6.7 | 0.2% | 0.5 |
| CB3417 (L) | 3 | unc | 6.7 | 0.2% | 0.2 |
| lLN2T_a (L) | 3 | ACh | 6 | 0.1% | 0.6 |
| ALON2 (L) | 1 | ACh | 5 | 0.1% | 0.0 |
| VP1l+_lvPN (L) | 2 | ACh | 5 | 0.1% | 0.5 |
| SAD009 (L) | 1 | ACh | 5 | 0.1% | 0.0 |
| lLN2P_c (L) | 2 | GABA | 3.7 | 0.1% | 0.8 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| M_l2PNm17 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| v2LN38 (L) | 2 | ACh | 2.7 | 0.1% | 0.0 |
| vLN25 (L) | 2 | Glu | 2.7 | 0.1% | 0.2 |
| M_smPNm1 (R) | 1 | GABA | 2.3 | 0.1% | 0.0 |
| v2LN50 (L) | 2 | Glu | 2.3 | 0.1% | 0.1 |
| lLN1_a (L) | 1 | ACh | 2 | 0.0% | 0.0 |
| ALIN2 (L) | 1 | ACh | 2 | 0.0% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 1.7 | 0.0% | 0.0 |
| M_lPNm11A (L) | 2 | ACh | 1.7 | 0.0% | 0.2 |
| CSD (R) | 1 | 5-HT | 1.3 | 0.0% | 0.0 |
| aDT4 (L) | 2 | 5-HT | 1.3 | 0.0% | 0.5 |
| lLN2P_a (L) | 1 | GABA | 1.3 | 0.0% | 0.0 |
| v2LN31 (L) | 1 | unc | 1.3 | 0.0% | 0.0 |
| GNG300 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| v2LN39a (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| lLN13 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| v2LN34E (L) | 3 | Glu | 1 | 0.0% | 0.0 |
| ALON1 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| M_ilPNm90 (R) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| M_lPNm11A (R) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 2 | OA | 0.7 | 0.0% | 0.0 |
| AL-AST1 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.3 | 0.0% | 0.0 |
| DNge075 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| M_lv2PN9t49_a (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| v2LN34A (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| M_l2PN3t18 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| HRN_VP1d | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CB1545 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |